[The antiviral activity of deitiforin in experimental para-influenza infection]. 1991

V K Boldasov, and N A Kalinina, and O V Revunova, and V M Guseva, and V M Leonov, and V P Sukhinin, and V I Il'enko

Deitiforin in HEp-2 cell culture was shown to inhibit replication of the reference PIV-3 strain when administered 1 hour before virus inoculation. The most marked effect of the drug was observed in the first 4 days of observation. In experimental newborn mice infected with parainfluenza virus 3 deitiforin protected the animals from developing the infection. In humans given deitiforin reaction to vaccination was found to develop 5-6 times more rarely than in the control group, PIV-3 could be isolated twice as rarely, and a diagnostically significant rise of specific antibody levels was observed less frequently.

UI MeSH Term Description Entries
D009930 Organic Chemicals A broad class of substances containing carbon and its derivatives. Many of these chemicals will frequently contain hydrogen with or without oxygen, nitrogen, sulfur, phosphorus, and other elements. They exist in either carbon chain or carbon ring form. Organic Chemical,Chemical, Organic,Chemicals, Organic
D010224 Parainfluenza Virus 3, Human A species of RESPIROVIRUS frequently isolated from small children with pharyngitis, bronchitis, and pneumonia. Hemadsorption Virus 1,Human parainfluenza virus 3,Para-Influenza Virus Type 3,Parainfluenza Virus Type 3,Para Influenza Virus Type 3
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000833 Animals, Suckling Young, unweaned mammals. Refers to nursing animals whether nourished by their biological mother, foster mother, or bottle fed. Animal, Suckling,Suckling Animal,Suckling Animals

Related Publications

V K Boldasov, and N A Kalinina, and O V Revunova, and V M Guseva, and V M Leonov, and V P Sukhinin, and V I Il'enko
January 2009, Voprosy virusologii,
V K Boldasov, and N A Kalinina, and O V Revunova, and V M Guseva, and V M Leonov, and V P Sukhinin, and V I Il'enko
January 1978, Voprosy virusologii,
V K Boldasov, and N A Kalinina, and O V Revunova, and V M Guseva, and V M Leonov, and V P Sukhinin, and V I Il'enko
June 1971, Meditsinskaia sestra,
V K Boldasov, and N A Kalinina, and O V Revunova, and V M Guseva, and V M Leonov, and V P Sukhinin, and V I Il'enko
December 1975, The Journal of antimicrobial chemotherapy,
V K Boldasov, and N A Kalinina, and O V Revunova, and V M Guseva, and V M Leonov, and V P Sukhinin, and V I Il'enko
October 1978, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
V K Boldasov, and N A Kalinina, and O V Revunova, and V M Guseva, and V M Leonov, and V P Sukhinin, and V I Il'enko
January 1971, Medycyna doswiadczalna i mikrobiologia,
V K Boldasov, and N A Kalinina, and O V Revunova, and V M Guseva, and V M Leonov, and V P Sukhinin, and V I Il'enko
January 1980, Farmakologiia i toksikologiia,
V K Boldasov, and N A Kalinina, and O V Revunova, and V M Guseva, and V M Leonov, and V P Sukhinin, and V I Il'enko
February 1990, Nihon rinsho. Japanese journal of clinical medicine,
V K Boldasov, and N A Kalinina, and O V Revunova, and V M Guseva, and V M Leonov, and V P Sukhinin, and V I Il'enko
January 1975, Zdravookhranenie Kirgizii,
V K Boldasov, and N A Kalinina, and O V Revunova, and V M Guseva, and V M Leonov, and V P Sukhinin, and V I Il'enko
January 2004, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
Copied contents to your clipboard!